CUC (2022): Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism

PREVIEW ARTICLE BEFORE SELECTION


Each Diplomate may only select eight articles. Please review prior to making your final selection. 

PDF iconRegimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism


NOTE: 

  1. The Diplomate may only attempt each assessment one time. The AUA will not re-set the assessment if the 80% passing rate is not met.
  2. Diplomates will have until October 31, 2023 to complete the activity. 

Target Audience

  • Urologist

Learning Objectives

After completing this activity, learners will be able to:

  1. Demonstrate an increased knowledge base of urology.
  2. Apply increased knowledge to improve the quality of patient care.
Course summary
Course opens: 
02/28/2022
Course expires: 
10/31/2023
Rating: 
0

EDUCATION COUNCIL DISCLOSURES

PDF icon Education Council Disclosures_2022.pdf

COI REVIEW WORK GROUP DISCLOSURES

PDF icon COI Review Work Group_2022.pdf

LIFE LONG LEARNING WORK GROUP DISCLOSURES

PDF icon Life Long Learning Work Group Disclosures_2022.pdf

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

Please login or register to take this course.

NOTE: 

  1. The Diplomate may only attempt each assessment one time. The AUA will not re-set the assessment if the 80% passing rate is not met.
  2. Diplomates will have until October 31, 2023 to complete the activity.